Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 · New England Journal of Medicine · 2,795 citations
https://doi.org/10.1056/nejmoa1011802
C
C. David Mazer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
561
Papers
28.0K
Citations
73
h-index
245
i10-index
C. David Mazer is an academic researcher from St. Michael's Hospital. The author has contributed to research in topics: Cardiac, Anesthesia and Surgical Outcomes & Blood transfusion and management & Diabetes Treatment and Management. The author has an h-index of 73, co-authored 477 publications.
ORCID: 0000-0003-2566-4308Papers by this author
worksLeft Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
2021 · New England Journal of Medicine · 661 citations
https://doi.org/10.1056/nejmoa2101897
A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications
2018 · British Journal of Anaesthesia · 391 citations
https://doi.org/10.1016/j.bja.2018.02.007
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial
2018 · Diabetologia · 121 citations
https://doi.org/10.1007/s00125-018-4644-9
Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes
2020 · British Journal of Anaesthesia · 107 citations
https://doi.org/10.1016/j.bja.2020.09.023
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
2021 · JACC. Cardiovascular imaging · 90 citations
https://doi.org/10.1016/j.jcmg.2020.10.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat